Brief: Abvc Biopharma Says Nasdaq Granted Co An Extension To Comply With A Listing Rule

ABVC Biopharma

14/07/2023 22:28

July 14 (Reuters) - ABVC Biopharma Inc  ABVC.O :
    * ABVC BIOPHARMA - ON JULY 10, NASDAQ GRANTED CO AN
EXTENSION TO
COMPLY WITH LISTING RULE 5550(B)(1)
    * ABVC BIOPHARMA INC - MUST NOW ACHIEVE COMPLIANCE WITH
LISTING
RULE 5550(B)(1) ON OR BEFORE AUGUST 31, 2023

Further company coverage:  ABVC.O